¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÆó¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 KALC International Conference (2ÀÏÂ÷) : 2021-11-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÆó¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 KALC International Conference (2ÀÏÂ÷) : 2021-11-26
±³À°ÀÏÀÚ : 2021-11-26
±³À°Àå¼Ò : ¿Â¶óÀÎ Çмú´ëȸ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021 KALC International Conference (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540  
À̸ÞÀÏ : kalc@lungca.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú      
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ08:00~08:50 Overcoming Resistance to Immune-Targeted Therapies  Fabrice Barlesi(Gustave Roussy France) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ08:50~09:10 Radial EBUS Guided TBLB for Peripheral Pulmonary Lesions  June Hong Ahn(Yeungnam Univ.) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ09:10~09:30 ENB-Guided Preoperative Localization for Small Pulmonary Nodules  In Kyu Park(Seoul National Univ.) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ09:30~09:50 ENB-Guided Ablative Therapy  Calvin S. H. Ng(The Chinese Univ. of Hong Kong Hong Kong) 
È޽Ġ11-26 ¿Â¶óÀΠ09:50~10:10   () 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ10:10~10:35 How to Handle Oligometastatic Disease in Non-Small Cell Lung Cancer  Hauke Winter(Universitätsklinikum Heidelberg Germany) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ10:35~11:00 Surgical Role in Oligometastasis to Spines  Seung-Jae Hyun(Seoul National Univ.) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ11:00~11:25 Local Ablative Therapy with Radiation in Extra-Thoracic Visceral Oligometastasis  Jin Ho Kim(Seoul National Univ.) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ11:25~12:10 Lorlatinib: Clinical Data and Implications for the Sequential Therapy in Anaplastic Lymphoma Kinase+ Non-Small Cell Lung Cancer  Benjamin J Solomon(Peter MacCallum Cancer Centre Australia) 
½Ä»ç 11-26 ¿Â¶óÀΠ12:10~13:00   () 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ13:00~13:25 Oligometastasis with Radiotherapy and Immunotherapy  Ralph Weichselbaum(The University of Chicago Medicine USA) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ13:25~13:50 T Cell Metabolism and CAR-T  Hongbo Chi(St. Jude Children) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ13:50~14:15 Cold to Hot Conversion  In-San Kim(KIST) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ14:15~14:40 How Can We Enhance the Treatment Responses of Anti-PD-1 in Cancers?  Su-Hyung Park(KAIST) 
È޽Ġ11-26 ¿Â¶óÀΠ14:40~15:00   () 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ15:00~15:25 Predictive Biomarkers to Immune Checkpoint Blockade  Hye Ryun Kim(Yonsei Univ) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ15:25~15:50 Resistance Mechanisms to Immune Checkpoint Blockade  Se-Hoon Lee(Sungkyunkwan Univ.) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ15:50~16:15 Novel Immune Checkpoint Blockade  Se Hoon Park(Sungkyunkwan Univ.) 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ16:15~16:40 Immunotherapy Beyond Immune Checkpoint Blockade  Ross Soo(National Univ. Cancer Institute Singapore) 
È޽Ġ11-26 ¿Â¶óÀΠ16:40~16:50   () 
±³À°½Ã°£ 11-26 ¿Â¶óÀΠ16:50~17:40 Shifting Paradigm in EGFRm Non-Small Cell Lung Cancer Treatment from Early to Advance Stage Patients  Helena A. Yu(MSKCC USA) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÆó¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 KALC International Conference (2ÀÏÂ÷) : 2021-11-26""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2021 ´ëÇѳúÀüÁõÇÐȸ 11¿ù °³¿øÀÇ ¿¬¼ö°­Á : 2021-11-28
´ÙÀ½±Û °ø°øÀÇ·á´Â °ø°øº´¿ø¸¸ÀÇ Àǹ«ÀÌ°í ¿ªÇÒÀΰ¡? ±× ³íÀï¿¡ ´ëÇÏ¿© : 2021-11-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
15 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-29 0 690 2018-07-28
14 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø ¿µ»óȹµæÀÇ ±â¼úÀû Ãø¸é°ú Æó¾Ï °ËÁø : 2018-07-29 0 737 2018-07-28
13 ¼­¿ï ´ëÇѺÎÀÎÁ¾¾çÇÐȸ KGOG 2018 Summer Workshop Uterine Cancer : 2018-07-29 0 861 2018-07-28
12 ¼­¿ï ´ëÇÑ¿µ»óÀÇÇÐȸ »ó±ÙÀÇ»ç À¯¹æÃÔ¿µ¿ëÀåÄ¡ Ç°Áú°ü¸® ±³À° 3ÀÏÂ÷(7¿ù29ÀÏ) : 2018-07-29 0 796 2018-07-28
11 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-29 0 813 2018-07-28
10 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 18 ȸ ü°èÀû ¹®Çå °íÂû[¸ÞŸºÐ¼®]À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥ : 2018-07-28 0 1,146 2018-07-28
9 °æ±â ¸íÁöº´¿ø ¿äÃò ¹× ½½°üÀý ÅëÁõ Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-07-28 0 1,109 2018-07-28
8 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-28 0 1,063 2018-07-28
7 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2018³â ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2018-07-28 0 985 2018-07-28
6 °æ±â ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ 2018 Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC) Symposium : 2018-07-28 0 1,226 2018-07-28
5 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hyperhidrosis Symposium : 2018-07-28 0 1,514 2018-07-28
4 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø 2018 The 11th Catholic Neurosurgery Update Symposium : 2018-07-28 0 1,392 2018-07-28
3 °æ±â ´ëÇÑ´ç´¢º´ÇÐȸ °æÀÎÁöȸEGDM (Essential Guideline to Diabetes Management) : 2018-07-28 0 2,201 2018-07-28
2 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-28 0 1,425 2018-07-28
1 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¼ºÇü¿Ü°ú °­³² Áý´ãȸ : 2018-07-28 0 1,977 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷